buzzberg
Guide
Ideas
Daily Alpha
Feed
Sentiment
Strategy Lab
Callfolio
Speakers
MCP
Search
English
한국어
Sign in
×
Navigation
Guide
Radar
Daily Alpha
Feed
Sentiment
Strategy Lab
Callfolio
Leaderboard
MCP
FAQ
Open section
Radar
Feed
Sentiment
Callfolio
Leaderboard
$DFTX: Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
u/Danyzinho29 · Reddit — r/biotech_stocks ·
September 08, 2026 at 19:35
· ⬆ 3 pts · 💬 1 comments |
View on Reddit ↗
AI Summary
{"summary": "", "reason": "news_headline_only", "ideas": [], "model": "deepseek-v4-flash"}
Score
3
Comments
1
▶
Full Post Text
$DFTX: Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
More from Reddit — r/biotech_stocks
Why is Roivant (ROIV) up ~18%? Its lung drug cut artery pressure 56% when 20% was the bar
Sep 08, 19:26
$LFCR Settlement Update: Late Claims Are Being Considered in $3.75M Lifecore Biomedical Settlement
Sep 08, 17:20
$CNTB Has Two Phase 2 Results Coming This Month. Anyone Else Watching This?
Sep 08, 15:04
$MDWD A $400M Drug Has a Speed Problem. MediWound May Have the Answer.
Sep 08, 14:50
Shorting Opportunity: $EXEL
Sep 08, 14:47
🍪 Cookies
We use cookies to operate this site and for analytics. Declining won't affect your access to content.
Decline
Accept